Wellgistics Health Announces Convertible Note Financing Agreement

An update from Wellgistics Health Inc ( (WGRX) ) is now available.

On January 16, 2026, Wellgistics Health, Inc. entered into a private note purchase agreement with accredited investors to issue up to $8.125 million in secured convertible promissory notes, with $6.5 million in gross proceeds reflecting a 20% original issue discount. The notes, which carry 0% interest absent default and mature on the earlier of six months from issuance or the closing of a qualified financing, are convertible at the holder’s election into common stock at a fixed price of $0.4057 per share and are fully guaranteed and secured by the assets and intellectual property of the company and its wholly owned subsidiaries. As part of the deal, investors received participation rights in future offerings and the company agreed to significant limitations on incurring additional debt or granting new liens while the notes remain outstanding, tightening its capital structure but enhancing creditor protections. Also on January 16, 2026, Wellgistics retained Dawson James Securities, Inc. as placement agent, paying a 6.5% selling commission on gross proceeds and issuing common stock purchase warrants equal to 5% of gross proceeds, with all securities issued in reliance on private placement exemptions under the Securities Act.

More about Wellgistics Health Inc

Wellgistics Health, Inc. operates in the health sector, though this filing centers on its corporate financing activities rather than detailing specific products, services, or market segments. The company utilizes private capital markets and structured debt instruments to fund its operations and growth, reflecting an investor base comprised of accredited investors participating through exempt securities offerings.

Average Trading Volume: 14,414,735

Technical Sentiment Signal: Strong Sell

Current Market Cap: $36.4M

Learn more about WGRX stock on TipRanks’ Stock Analysis page.